Error: Could not add to watchlist. X

CFS Managed Investment Fund - Global Health & Biotechnology

+ Watchlist
COLFHLB:AU
2.44
AUD
0.04
1.61%
As of 00:59:30 ET on 08/04/2015.
Fund Type
Unit Trust
52Wk Range
1.40 - 2.48
1 Yr Return
71.24%
YTD Return
31.60%
Previous Close
2.48
52Wk Range
1.40 - 2.48
1 Yr Return
71.24%
YTD Return
31.60%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 08/04/2015)
2.4384
Total Assets (m AUD) (on 02/27/2015)
26.299
Inception Date
04/28/2000
Last Dividend (on 06/30/2015)
-
Dividend Indicated Gross Yield
-
Fund Managers
DAVID L LEARY
Front Load Fee
4.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
2.05%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Bristol-Myers Squibb Co 18.95 k 1.59 m 6.05
Medtronic PLC 15.77 k 1.56 m 5.95
Gilead Sciences Inc 9.34 k 1.36 m 5.19
Allergan plc 3.02 k 1.21 m 4.60
Regeneron Pharmaceuticals Inc 1.49 k 999.37 k 3.80
McKesson Corp 3.13 k 970.44 k 3.69
UnitedHealth Group Inc 5.88 k 920.47 k 3.50
Aetna Inc 5.54 k 852.09 k 3.24
HCA Holdings Inc 6.20 k 662.74 k 2.52
Alkermes PLC 7.48 k 596.99 k 2.27
Profile
CFS Managed Investment Fund - Global Health & Biotechnology is a unit trust incorporated in Australia. The objective of the Fund is to provide long-term capital growth by predominantly investing in companies around the world, whose primary business is in the fields of pharmaceuticals, biotechnology, medical devices, or medical services.
ADDRESS
Colonial First State Asset Mgt Ltd
11 Harbour Street
Sydney NSW 2000
Australia
PHONE
Tel: 61-2-9303-3000